INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2021

A review of Withania somnifera reports potential anti-cancer activities and quality-of-life benefits in breast cancer models and trials.

This review synthesized in vitro, in vivo, and clinical studies published between 2000 and 2019 evaluating Withania somnifera (Ashwagandha) against breast cancer. Researchers reported anti-apoptotic, anti-metastatic, anti-invasive, and anti-inflammatory properties, with potential for treating ER/PR positive and triple-negative breast cancer. A past clinical trial also suggested potential for refining quality of life in breast cancer patients. The authors call for future translational studies involving breast cancer patients.

Study type
Narrative review
Who was studied
In vitro, in vivo, and clinical studies (2000–2019)
What was measured
Anticancer activity, molecular mechanisms, and quality of life in breast cancer

THE PAPER

Keeping abreast about ashwagandha in breast cancer.

Vashi R, Patel BM, Goyal RK. J Ethnopharmacol, 2021.

PubMed 33359916 ↗DOI 10.1016/j.jep.2020.113759 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.